Log in
Enquire now
‌

US Patent 11596694 Compositions and methods for predicting response to NaPi2b-targeted therapy

Patent 11596694 was granted and assigned to Mersana Therapeutics on March, 2023 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

This disclosure provides reagents and methods of predicting the responsiveness of a patient to NaPi2b-targeted antibody-drug conjugates (e.g., NaPi2b-targeted antibody-polymer-drug conjugates).

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11596694 Compositions and methods for predicting response to NaPi2b-targeted therapy

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo